Multiple sclerosis (MS) is a chronic demyelinating disease that is associated with permanent disability and low quality of life. Development of MS is attributed to a combination of genetic and environmental factors. Genome-wide association studies revealed more than 200 variants that are associated with risk of MS. An umbrella review showed that smoking, history of infectious mononucleosis, and anti-Epstein–Barr virus nuclear antigen (anti-EBNA) immunoglobulin G (IgG) seropositivity are credible risk factors of MS. In the present narrative review, we updated our published umbrella review, showing that body mass index in childhood and adolescence and anti-viral capsid antigen (anti-VCA) IgG seropositivity are additional credible risk factors of MS. In addition, we discuss the findings from Mendelian randomization studies, which present evidence for a potential causal role of serum vitamin D and adulthood body mass index on risk of MS. Finally, we discuss the potential limitations of meta-analyses, umbrella reviews, and Mendelian randomization studies in the search for risk factors of MS.
ThompsonAJBaranziniSEGeurtsJ, et al. Multiple sclerosis. Lancet2018; 391: 1622–1636.
2.
PatsopoulosNA.Genetics of multiple sclerosis: An overview and new directions. Cold Spring Harb Perspect Med2018; 8: a028951.
3.
International Multiple Sclerosis Genetics Consortium. Low-frequency and rare-coding variation contributes to multiple sclerosis risk. Cell2018; 175: 1679–1687.e7.
4.
RamagopalanSVDobsonRMeierUC, et al. Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurol2010; 9(7): 727–739.
5.
HarroudARichardsJB.Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity. Mult Scler2018; 24(1): 80–85.
6.
IoannidisJPA. Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ2009; 181(8): 488–493.
7.
BellouVBelbasisLTzoulakiI, et al. Environmental risk factors and Parkinson’s disease: An umbrella review of meta-analyses. Parkinsonism Relat Disord2016; 23: 1–9.
8.
IoannidisJPABoffettaPLittleJ, et al. Assessment of cumulative evidence on genetic associations: Interim guidelines. Int J Epidemiol2008; 37(1): 120–132.
9.
BelbasisLPanagiotouOADosisV, et al. A systematic appraisal of field synopses in genetic epidemiology: A HuGE review. Am J Epidemiol2015; 181(1): 1–16.
10.
BelbasisLBellouVEvangelouE, et al. Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses. Lancet Neurol2015; 14(3): 263–273.
11.
BelbasisLBellouVEvangelouE.Environmental risk factors and amyotrophic lateral sclerosis: An umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology2016; 46(2): 96–105.
12.
BellouVBelbasisLTzoulakiI, et al. Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses. Alzheimers Dement2017; 13(4): 406–418.
HigginsJPTThompsonSGDeeksJJ, et al. Measuring inconsistency in meta-analyses. BMJ2003; 327(7414): 557–560.
15.
IoannidisJPATrikalinosTA. An exploratory test for an excess of significant findings. Clin Trials2007; 4: 245–253.
16.
HandelAEWilliamsonAJDisantoG, et al. Smoking and multiple sclerosis: An updated meta-analysis. PLoS ONE2011; 6(1): e16149.
17.
HandelAEWilliamsonAJDisantoG, et al. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS ONE2010; 5(9): e12496.
18.
AlmohmeedYHAvenellAAucottL, et al. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis. PLoS ONE2013; 8(4): e61110.
19.
SaberiRSharifMSarviS, et al. Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. J Neuroimmunol2018; 322: 57–62.
20.
MouchetJSalvoFRaschiE, et al. Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis. Pharmacol Res2018; 132: 108–118.
21.
YaoGWangPLuoX-D, et al. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis. Neurosci Lett2016; 620: 1–7.
22.
PormohammadAAzimiTFalahF, et al. Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis. J Cell Physiol2018; 233(4): 2850–2862.
23.
LiuZZhangT-TYuJ, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: A meta-analysis. Neuroepidemiology2016; 47(2): 103–108.
24.
ZhuTYeXZhangT, et al. Association between alcohol consumption and multiple sclerosis: A meta-analysis of observational studies. Neurol Sci2015; 36(9): 1543–1550.
25.
DaveySmith GEbrahimS.Mendelian randomization: Prospects, potentials, and limitations. Int J Epidemiol2004; 33(1): 30–42.
26.
LawlorDAHarbordRMSterneJAC, et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med2008; 27: 1133–1163.
27.
EggerMDaveySmith GSterneJAC. Uses and abuses of meta-analysis. Clin Med (Lond)2001; 1: 478–484.
28.
RamagopalanSVValdarWCriscuoliM, et al. Age of puberty and the risk of multiple sclerosis: A population based study. Eur J Neurol2009; 16: 342–347.
29.
NielsenNMHarpsoeMSimonsenJ, et al. Age at menarche and risk of multiple sclerosis: A prospective cohort study based on the Danish national birth cohort. Am J Epidemiol2017; 185(8): 712–719.
30.
EvansDMDavey SmithG.Mendelian randomization: New applications in the coming age of hypothesis-free causality. Annu Rev Genomics Hum Genet2015; 16: 327–350.
31.
DaviesNMHolmesMVDavey SmithG.Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ2018; 362: k601.
32.
GianfrancescoMAStridhPRheadB, et al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology2017; 88(17): 1623–1629.
33.
DevorakJMokryLEMorrisJA, et al. Large differences in adiponectin levels have no clear effect on multiple sclerosis risk: A Mendelian randomization study. Mult Scler2017; 23(11): 1461–1468.
34.
GianfrancescoMAGlymourMMWalterS, et al. Causal effect of genetic variants associated with body mass index on multiple sclerosis susceptibility. Am J Epidemiol2017; 185(3): 162–171.
35.
MokryLERossSAhmadOS, et al. Vitamin D and risk of multiple sclerosis: A Mendelian randomization study. PLoS Med2015; 12: e1001866.
36.
MokryLERossSTimpsonNJ, et al. Obesity and multiple sclerosis: A Mendelian randomization study. PLoS Med2016; 13(6): e1002053.
37.
RheadBBaarnhielmMGianfrancescoM, et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol Genet2016; 2(5): e97.
38.
BurgessSBowdenJFallT, et al. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology2017; 28(1): 30–42.
39.
WinklerTWJusticeAEGraffM, et al. The influence of age and sex on genetic associations with adult body size and shape: A large-scale genome-wide interaction study. PLoS Genet2015; 11: e1005378.
40.
ElksCELoosRJFHardyR, et al. Adult obesity susceptibility variants are associated with greater childhood weight gain and a faster tempo of growth: The 1946 British Birth Cohort Study. Am J Clin Nutr2012; 95(5): 1150–1156.
41.
BowdenJDavey SmithGBurgessS.Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol2015; 44(2): 512–525.
42.
VerbanckMChenC-YNealeB, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet2018; 50: 693–698.
43.
BurgessSThompsonSG.Multivariable Mendelian randomization: The use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol2015; 181: 251–260.
44.
International Multiple Sclerosis Genetics Consortium. The multiple sclerosis genomic map: Role of peripheral immune cells and resident microglia in susceptibility. bioRxiv2017, https://www.biorxiv.org/content/10.1101/143933v1
45.
EvangelouEIoannidisJPA. Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet2013; 14(6): 379–389.
